CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada from $60.00 to $53.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would suggest a potential upside of […]
More Stories
Citigroup Increases Medtronic (NYSE:MDT) Price Target to $92.00
Medtronic (NYSE:MDT – Free Report) had its target price increased by Citigroup from $85.00 to $92.00 in a research note...
Integer (NYSE:ITGR) Price Target Raised to $145.00
Integer (NYSE:ITGR – Free Report) had its price objective lifted by Bank of America from $135.00 to $145.00 in a...
UN condemns deadly West Bank airstrike, attacks on Gaza schools
The UN chief has strongly condemned the killing of several Palestinians, including women and children, who died when a residential...
Lamb Weston (NYSE:LW) Releases FY 2025 Earnings Guidance
Lamb Weston (NYSE:LW – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per...
Dbs Bank Upgrades Volkswagen (OTCMKTS:VWAGY) to “Hold”
Volkswagen (OTCMKTS:VWAGY – Get Free Report) was upgraded by Dbs Bank to a “hold” rating in a research note issued...
News from the WHO: WHO adds an HPV vaccine for single-dose use https://ift.tt/wCOnRQP October 04, 2024 at 07:00AM
Published on October 04, 2024 at 07:00AM View on website